Search

Author/Creator Isenberg, David A

1. 102 M-Phase Phosphoprotein 1 (MPP-1) Autoantibodies as a Potential Biomarker for Cranial Neuropathies in an International SLE Inception Cohort. (14th December 2022)

Authors:
Krustev, Eugene; Hanly, John G; Chin, Ricky; Buhler, Katherine; Cardwell, Francesca; Urowitz, Murray B; Gordon, Caroline; Bae, Sang-Cheol; Romero-Diaz, Juanita; Sanchez-Guerrero, Jorge; Bernatsky, Sasha; Wallace, Daniel J; Isenberg, David A; Rahman, Anisur; Merrill, Joan T; Fortin, Paul R; Gladma...
Journal:
Lupus science & medicine
Issue:
Volume 9(2022)Supplement 3
Page Start:
A2
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends. (October 2020)

Authors:
Cohen, Hannah; Cuadrado, Maria J; Erkan, Doruk; Duarte-Garcia, Ali; Isenberg, David A; Knight, Jason S; Ortel, Thomas L; Rahman, Anisur; Salmon, Jane E; Tektonidou, Maria G; Williams, David J; Willis, Rohan; Woller, Scott C; Andrade, Danieli
Journal:
Lupus
Issue:
Volume 29:Number 12(2020)
Page Start:
1571
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 242 Baseline characteristics of patients with lupus nephritis requiring rituximab therapy: results from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR). (12th April 2019)

Authors:
Collinson, Sophie; Parker, Ben; McCarthy, Eoghan M; Sutton, Emily; Jayne, David; Griffiths, Bridget; Isenberg, David A; Rahman, Anisur; Gordon, Caroline; D'Cruz, David P; Hewins, Peter; Rhodes, Benjamin; Lanyon, Peter; Vital, Edward M; Yee, Chee-Seng; Edwards, Christopher J; Teh, Lee-Suan; Akil, ...
Journal:
Rheumatology
Issue:
Volume 58(2019)Supplement 3
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 603 Remission and low disease activity are associated with lower health care costs in an international inception cohort of patients with systemic lupus erythematosus. (14th December 2022)

Authors:
Clarke, Ann E; Ugarte-Gil, Manuel Francisco; Barber, Megan RW; Hanly, John G; Urowitz, Murray B; Pierre, Yvan St; Gordon, Caroline; Bae, Sang-Cheol; Romero-Diaz, Juanita; Sanchez-Guerrero, Jorge; Bernatsky, Sasha; Wallace, Daniel J; Isenberg, David A; Rahman, Anisur; Merrill, Joan T; Fortin, Paul...
Journal:
Lupus science & medicine
Issue:
Volume 9(2022)Supplement 3
Page Start:
A26
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE. (17th January 2020)

Authors:
van Dam, Laura S; Osmani, Zgjim; Kamerling, Sylvia W A; Kraaij, Tineke; Bakker, Jaap A  ; Scherer, Hans U; Rabelink, Ton J; Voll, Reinhard E; Alexander, Tobias; Isenberg, David A; van Kooten, Cees; Teng, Y K Onno
Journal:
Rheumatology
Issue:
Volume 59:Number 10(2020)
Page Start:
2734
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Anti-protein C antibodies and acquired protein C resistance in SLE: novel markers for thromboembolic events and disease activity?. (23rd September 2020)

Authors:
Ramirez, Giuseppe A; Mackie, Ian; Nallamilli, Susanna; Pires, Tatiana; Moll, Rachel; Pericleous, Charis; Isenberg, David A; Cohen, Hannah; Efthymiou, Maria
Journal:
Rheumatology
Issue:
Volume 60:Number 3(2021)
Page Start:
1376
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study. (March 2020)

Authors:
Fisher, Benjamin A; Szanto, Antonia; Ng, Wan-Fai; Bombardieri, Michele; Posch, Maximilian G; Papas, Athena S; Farag, Arwa M; Daikeler, Thomas; Bannert, Bettina; Kyburz, Diego; Kivitz, Alan J; Carsons, Steven E; Isenberg, David A; Barone, Francesca; Bowman, Simon J; Espié, Pascal; Floch, David; Du...
Journal:
Lancet
Issue:
Volume 2:Number 3(2020)
Page Start:
e142
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Attainment of treat-to-target endpoints in SLE patients with high disease activity in the atacicept phase 2b ADDRESS II study. (27th February 2020)

Authors:
Morand, Eric F; Isenberg, David A; Wallace, Daniel J; Kao, Amy H; Vazquez-Mateo, Cristina; Chang, Peter; Pudota, Kishore; Aranow, Cynthia; Merrill, Joan T
Journal:
Rheumatology
Issue:
Volume 59:Number 10(2020)
Page Start:
2930
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗